Ozempic’s Maker Got Crushed. The Rebound Is Under Way.

The Wall Street JournalSunday, September 21, 2025 at 11:00:00 AM
Ozempic’s Maker Got Crushed. The Rebound Is Under Way.
Novo Nordisk, the maker of Ozempic, is showing signs of recovery after facing challenges. With a new weight-loss pill on the way and the FDA indicating a stricter approach to compounded knockoffs, the company may be on the verge of a turnaround. This is significant as it highlights the potential for innovation in weight management solutions and the importance of regulatory support in ensuring market integrity.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
I used medication to overcome alcohol addiction. I’ve built my business on it
PositiveFinancial Markets
In a powerful personal account, an individual shares how naltrexone helped them overcome alcohol addiction and inspired them to build a successful business. This story highlights the effectiveness of this FDA-approved medication, which is safe and non-addictive, and sheds light on the diverse perspectives within the Alcoholics Anonymous community regarding its use. It matters because it challenges traditional views on addiction treatment and offers hope to many seeking recovery.
Exclusive-FDA nicotine pouch pilot to ease manufacturers’ research burden, transcript shows
PositiveFinancial Markets
The FDA is launching a pilot program aimed at easing the research burden on manufacturers of nicotine pouches. This initiative is significant as it could streamline the approval process for new products, encouraging innovation in the market. By reducing the regulatory hurdles, the FDA hopes to foster a safer and more diverse range of nicotine alternatives, which could benefit consumers looking for less harmful options.
Despite Heavy Marketing, Most Americans Reject the New Weight Loss Drugs
NegativeFinancial Markets
A recent national survey reveals that despite heavy marketing efforts, most Americans are not interested in new weight-loss injectables like Wegovy and Ozempic. This is significant because it highlights a disconnect between pharmaceutical advertising and public acceptance, suggesting that many may prefer traditional methods such as diet changes. The research published in the Journal of the American College of Nutrition indicates that a vegan diet may be more effective for weight loss than the Mediterranean diet, prompting a reevaluation of dietary approaches in the weight loss conversation.
FDA OKs New Keytruda Shot for Cancer
NegativeFinancial Markets
The FDA has approved Merck's new injected version of Keytruda, a significant cancer treatment. While this innovation promises quicker and easier administration, it raises concerns about potentially slowing the adoption of more affordable alternatives, which could lead to increased healthcare costs by billions. This development is crucial as it highlights the ongoing tension between innovation and accessibility in cancer care.
Exclusive-FDA nicotine pouch pilot to ease manufacturers’ research burden, transcript shows
PositiveFinancial Markets
The FDA is launching a pilot program aimed at easing the research burden on manufacturers of nicotine pouches. This initiative is significant as it could streamline the approval process for new products, allowing for quicker innovation in the market. By reducing the regulatory hurdles, the FDA hopes to encourage more research and development in the nicotine pouch sector, ultimately benefiting consumers with more options and potentially safer products.
Novo Nordisk cuts U.S. sales team as part of broader restructuring - Reuters
NegativeFinancial Markets
Novo Nordisk's decision to cut its U.S. sales team is part of a larger restructuring effort, which raises concerns about the company's future direction and its impact on employees. This move reflects the challenges faced by pharmaceutical companies in adapting to changing market conditions and could affect their ability to effectively promote their products.
Exclusive-Novo Nordisk cuts US obesity education team as layoffs begin, say sources, online posts
NegativeFinancial Markets
Novo Nordisk is reportedly reducing its US obesity education team as part of a wave of layoffs, raising concerns about the future of obesity management and support in the country. This move could impact the availability of resources for patients and healthcare providers, highlighting the challenges in addressing obesity as a public health issue. The decision reflects broader trends in the healthcare industry, where companies are reassessing their strategies amid economic pressures.
FDA approves OrganOx liver transport device for air travel
PositiveFinancial Markets
The FDA has approved the OrganOx liver transport device for air travel, marking a significant advancement in organ transplantation. This device allows for the safe and efficient transport of livers, which can enhance the chances of successful transplants and save more lives. With this approval, hospitals can now expand their donor networks and improve patient outcomes, making it a crucial development in the field of healthcare.
Novo Nordisk shares climb after positive results for anti-obesity pill
PositiveFinancial Markets
Novo Nordisk's shares surged by approximately £9 billion after promising trial results for its new anti-obesity pill, which demonstrated significant weight loss comparable to its existing Wegovy injection. This development is crucial as the company competes with Eli Lilly to bring an effective tablet treatment to market, potentially reshaping the obesity treatment landscape and offering new hope for those struggling with weight management.
Latest from Financial Markets
Israel stocks lower at close of trade; TA 35 down 1.58%
NegativeFinancial Markets
Israel's stock market faced a downturn as the TA 35 index closed down by 1.58%. This decline reflects ongoing economic concerns and market volatility, which can impact investor confidence and future trading activities. Understanding these trends is crucial for investors and analysts alike, as they navigate the complexities of the financial landscape.
Canada joins Britain and Australia in recognizing a Palestinian state despite opposition from the U.S.
PositiveFinancial Markets
Canada's recent decision to recognize a Palestinian state aligns it with Britain and Australia, marking a significant step in international diplomacy. This move is important as it reflects a growing global consensus, with over 145 countries already acknowledging Palestinian statehood, despite opposition from the U.S. It highlights Canada's commitment to supporting self-determination and could influence other nations to reconsider their stance.
Hot chicken fast-food chain closes all restaurants, no bankruptcy
NegativeFinancial Markets
The popular hot chicken fast-food chain has decided to close all its restaurants, which is disappointing news for fans of Nashville-style hot chicken. Despite its efforts to expand into new markets, the chain has not filed for bankruptcy, leaving many to wonder about the future of this once-trendy dining option. This closure highlights the challenges faced by restaurants in a competitive market and raises questions about consumer preferences.
Wealth tax would be deadly for French economy, says Europe’s richest man
NegativeFinancial Markets
Bernard Arnault, the owner of LVMH and Europe's richest man, has voiced strong opposition to a proposed 2% wealth tax in France, warning that it could cost him over €1 billion and be detrimental to the country's economy. He argues that such a tax threatens the liberal economic framework that benefits everyone. This debate is significant as it highlights the tension between wealth redistribution efforts and the concerns of high-net-worth individuals about the impact of taxation on economic growth.
How ‘Safe China’ sells its security strategy to the world
NeutralFinancial Markets
The article discusses how China's security strategy, particularly its policing tactics and surveillance methods, is attracting interest from global leaders, including those from non-autocratic regimes. This trend highlights the growing influence of China's approach to governance and security on the international stage, raising questions about the implications for civil liberties and global norms.
The Fed Fractures Amid White House Influence, Stephen Miran Dissent
NegativeFinancial Markets
The recent Fed rate cut highlights a troubling trend within the Federal Reserve, revealing how political pressures from the White House are causing ideological fractures among its members. This division, particularly evident in Stephen Miran's dissent, raises concerns about the central bank's independence and its ability to respond effectively to mounting economic risks. As external influences grow, the Fed's decision-making process may become increasingly compromised, which could have significant implications for the economy.